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The  genes  Gm  ~ and  Gm  b have  generally  been  considered  to  be  alleles  in 
Caucasians  (1-3).  Studies  of  myeloma globulins  and  of  isolated  antibodies 
by several workers led to the conclusion that only a  minor proportion of the 
72-globulin  molecules  contain  the  expression  of  the  gene  Gm  b,  even  in  the 
Gm  b homozygote, whereas the gene Gm  ~ partakes in the synthesis of a  major 
fraction of  the "y2-globulin  (4-9).  A  large proportion  of  the  "y~-globulin  mol- 
ecules  in  Caucasian  individuals  possessing  the  gene  Gmb  seem  to  be 
Gm(a--b-). 
Recently another hereditary group characteristic of human "y-globulin was identi- 
fied and given the designation  Gin(f)  (10).  Gm(f+) -},-globulin is detected by means 
of rare human sera containing anti-Gin(f). Gold made the initial observation that a 
serum that apparently gave the  same results as an anti-Gm(b) when used to type 
whole sera agglutinated some anfi-Rh-coated red cells that were not agglutinable by 
anti-Gin(b).  The  agglutinator  of  this  serum  was  subsequently  named  anti-Gin(f) 
(10).  Other genetic factors of human "y-globulin that have recently been  reported 
are Gm (bw), (ba), (b~), (bY), (e), and (p), but Gm(f) does not seem to be identical 
with  any  of  these  (10). 
The characteristic Gin(f) was generally found to be inherited  together with 
Gin(b)  in  the  Caucasians  studied.  It  was  considered  possible  that  Gin(f) 
might correspond to a  gene involved in the synthesis of the  Gm(a--b--) "y,- 
globulins  found  in  Gin(b+)  white individuals.  This study is concerned  with 
the  definition  of  Gin  f  and  with  the  relationships  between  genes  Gm  t,  Gm  a, 
Gm  b, and their products. 
Material and Methods 
Gm Determinations 
Agglutination Inhibition Tests.-- 
Principle: Some human  sera agglutinate Rh-positive red  cells coated with  incomplete 
anti-Rh antibodies.  The agglutinator can sometimes  be shown to react with a genetic  ~,-globulln 
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determinant. Sera from individuals whose "y-globulin contains the specific determinant inhibit 
the agglutination. For example, a Gin(a) typing system consists of an anti-Gm(a) agglutinator 
and red cells coated with Gm(a+) anti-Rh antibodies; Gin(a+) sera inhibit the agglutination, 
while Gm(a-) sera do not. 
Reagents used: For all the Gm factors studied, i.e.  Gin(a), Co), (f), and (x), typing systems 
were used in which the agglutination was inhibited by Gin(+) sera diluted 1/100 or more but 
not by even undiluted Gm(-)  sera. 
1. Anti-Crm(f): Two sera, Mau. and A. J., were used (10). Both were from donors without 
signs of rheumatoid arthritis. On sucrose density gradient ultracentrifugation the agglutinators 
in the 2 sera sedlmented like 19S 7-globulins. They gave identical results when used for typing 
of  10 Negro  sera,  15 Eskimo sera,  and 30 Caucasian sera, including the Gm(b+f-)  and 
Gin(b-f+)  sera encountered; both of them agglutinated in parallel  red  ceils  coated  with 
various anti-Rh antibodies that did not coat for anti-Gin(a) or for anti-Gin(b); and both 
reacted with determinants recovered in the S fraction after papain digestion or %globulin (11). 
g. Anti-Crm(b):  Most  determinations  were  made  with  serum  I.  G.  which  contains  an 
anti-Gm(b) sedimenting like 7S 3"-globulin  (see  reference  12).  Five other anti-Gm(b) sera 
were  used  to  type  some  of  the  Gm(a-b-kf-)  myeloma  globulins and  gave  concordant 
results. 
3. AnH-Gm(a):  One  agglutinator from  a  healthy  donor,  B.  A.,  was  used  for  most  de- 
terminations. It gave identical results with 3 other anti-Gin(a) agglutinators (1 of which was 
of 7S type) in typings of 10 myeloma globulins of various Gm types,  15 Eskimo,  10 Negro, 
and 20 Caucasian sera. 
4. AnH-Crm(x): One serum from a non-rheumatoid subject, R. A., was used. 
5. AnH-In~(1)  and anti-Inv(a): Two anti-Inv(1) sera were provided by Dr. Ema v. Loghem, 
Amsterdam,  Netherlands, and  1 by Dr.  A.  G.  Steinberg, Cleveland. The anti-Inv(a)  used 
was the original serum, Virtu., of Dr. Ropartz, Rouen, France. 
Technique." 0.06 ml of the sample to be tested, 0.03 ml of the anti-Gin serum in a suitable 
dilution, and 0.03  ml of anti-Rh--eoated red cells in a  2  per cent suspension were mixed in 
round-bottom  test  tubes.  After  standing for  1 hour at  room  temperature  the  tubes were 
centrifuged for 45 seconds (serofuge,  Clay-Adams Inc., New York) and then read immediately 
for agglutination with the naked eye. Isotonic phosphate-buffered NaCI  (pH 7.2)  was used 
as a diluent. Conventional controls were included in all determinations. 
Most of the 620 Swedish sera were typed in 1 dilution,  1/15, in the Gin(a), (b), and  (f) 
systems. The Negro sera, as well as  100 of the Swedish sera, were typed in the 2 dilutions 
1/5 and 1/30, in both of which the results were always identical. 
The anti-Rh sera were typed in the dilutions 1/10,  1/20, and 1/40. Two special controls 
were included: (a) serum 1/10 -J- anti-Gm q- uncoated cells and (b) serum 1/10 +  saline + 
coated cells.  These controls were always negative. 
The myeloma sera and myeloma globulin preparations were  tested in series of twofold 
dilutions to determine the inhibitory titres in the different Gm typing systems. Pipettes were 
changed between the dilution steps. 
AggluHnation  Tes/s.--Some  experiments were  done  to  determine  the  Gm  types  of  the 
anti-Rh antibody molecules of certain sera. Tables VI a and VI b refers to an experiment in 
which 10 volumes of each anti-Rh serum diluted ~  was mixed with 1 volume of packed Rh- 
positive red cells.  After incubation at 37°C for 1 hour and repeated washing of the cells,  the 
latter were  tested for agglutinability by anti-Gm sera with a  technique analogous to  that 
described above. 
The experiment referred to in Table VII was done in a  similar way, except that 1 volume 
of a  20 per cent suspension of cells was coated with 4 volumes of different dilutions, given in 
the table, of the anti-Rh sera. LARS ~TENSSON  1171 
Mydoma Sera and Mydoma Globulin Preparations 
24 myeloma sera had been obtained from Dr. R. Bachmann,  Dr. C.-B. Laurell, and  Dr. 
U. Nilsson, the Department of Clinical Chemistry, Malm/~ General Hospital, Malmti, Sweden. 
Routine paper electrophoresis, starch gel electrophoresis, and immunoelectrophoresis, employ- 
ing specific anti-T2, aati-T1A, and anti-T,M-antisera, had been performed there. All sera con- 
tained  myeloma  globulins of immunological T2-type.  The  concentrations  of  the  myeloma 
globulins had  been determined by paper electrophoresis and  are given later on in Table V 
together with the results on each serum. Only sera with myeloma peaks above 35 mg/ml were 
included.  The levels of normal T-giobulin  (non-myeloma v-globulin) were depressed  in all 
sera. The estimated amount of normal v-globulin in these sera never exceeded 5 mg/ml. 
Immunoelectrophoresis  was  run  also  in  our  laboratory  on  those  myeloma  sera  that 
contained  Gin(a-b-f-)  myeloma globulin.  Specific  anti-T~-,  anti--T1A-, and  anti--TtM- 
rabbit antisera were used (Behringwerke A.G., Marburg-an-der-Lahn,  Germany). 
Of the 18 purified myeloma globulin preparations,  14 were obtained from the Department 
of Clinical Chemistry, Malm~ General Hospital, and 4 from Dr. H. G. Kunkel, The Rocke- 
feller Institute.  The procedures  used  for purification of the  14 preparations  from  Maim6 
have been described in references 8 and 13, that for the 4 preparations from The Rockefeller 
Institute in reference 6. All these preparations had been judged as  containing only traces of 
residual normal T-globulin. Gin(a) and (b) types of 4 of these were published  in reference 4, 
types of 10 in reference 8, and types of 4 in reference 6. 
Sera  from Caucasians and Negroes 
The Swedish sera  (Table I)  had  been sent  to our institute  for routine  serological  tests. 
Around  half were from normal blood donors and  half from patients  of a  Swedish general 
hospital. 
The 10 American Negro sera (Table I) were received from Dr. A. G. Steinberg, Western 
Reserve University, Cleveland. 
Anti-Rh Sera 
The incomplete anti-Rh  sera  used were gifts from several laboratories.  Two of the  sere 
identified in Table VI b have been used by other groups studying the Gm factors.  M. B. was 
received from Dr. C. K. Osterland, The Rockefeller Institute,  and 199 from the State Serum 
Institute, Copenhagen (equals their serum 423199). 
RESULTS 
Sera.-- 
Caucasians: Table I, A, gives the  Gm(a),  (b),  and  (f)  types of 560  Swedish 
sera. 
In addition  60 Swedish sera,  in which types  Gm(a-{-b-)  and  Gm(a+b+)  were inten- 
tionally  overrepresented were  typed  for  Gin(f).  All of 26  Gin(a-I-b-)  sera  proved  to  be 
Gin(f-).  Of 26 Gm(a+b-}-)  sera  1 was Gin(f-)  and  the rest Gin(f+).  All 8  Gin(a-b+) 
sera were found to be Gm(f+). 
Thus,  of  620  Swedish  sera  tested  all  except  3  were  Gm(b+f+)  or 
Gm(b-f--);  2  were  Gm(b+f--)  and  1  was  Gm(b-f+).  These  3  sera  have 
been  tested  repeatedly  and  with  both  of  the  anti-Gin(f)  agglutinators.  2  of 
3  sibs  of  a  Gm(a+bWf--)  individual  were  also  Gm(a+b+f--). 1172  ")'-GLOBULIN GE~TE  S 
Negroes: Of 10 American Negroes (Table I, B)  7 were Gm(a+b+f--)  and 
3 were Gm(a+b+f+). 
Myeloma Globulins.--The "y2-mydoma globulin in 24 sera and in 18 purified 
myeloma  globulin  preparations  from  Caucasian  individuals  were  grouped 
with  respect  to  Gm(a),  (b),  (f),  and  (x)  (Tables II to  IV). 
TABLE I 
Can Types of 560 Swedish Sera and 10 Amerir,  an Negro Sera 
Sera  No.  Per cent 
A.  Swedish 
Gm(a+b+f+) 
Gm(a-b+f+) 
Gm(a+b-f-) 
Gm(a+b+f-) 
Gm(a+b-f+) 
Total ....................... 
B. American Negro 
Gm(a+b+f+) 
Gm(a+b+f--) 
Total ...................... 
248 
235 
75 
1 
1 
560 
I0 
44 
42 
13 
<1 
<1 
When  typed with  respect  to  a  particular  Gm factor,  i.e.  Gm(a),  (b),  (f), 
or  (x), each myeloma serum (or myeloma globulin preparation)  fell into one 
or  another  of the  following categories: 
A.  Sera  without the specific activity: Gin(--) normal and mydoma globulin. 
B.  Sera with activity approximately equal to that of normal Gin(+) sera (or lower and 
then proportional to the decreased concentration of the normal "y-globulin): Gin(+) normal 
and Can(-)  mydoma "y-globulin. 
C.  Sera with  activity  considerably higher than  that  of normal  Gin(+)  sera:  Can(W) 
mydoma  globulin. 
As an example, the results  of Gin(a)  determinations on the myeloma sera 
are given in Fig. 1. The 6 myeloma sera which were Gm(a--) are not included. 
Of  the  18  Gm(a+)  myeloma sera  7  constitute  1  group  (hatched  columns). 
They had inhibitory titres that were on the average slightly lower than those 
of normal Gm(a+) sera (Fig.  1, upper  diagram).  These  titres  corresponded 
to  the  decreased  concentrations  of  normal  ~,-globulin.  The  other  11  (filled 
columns)  had  considerably  higher  inhibitory  titres  than  Gm(a+)  normal 
sera (Fig.  1, upper diagram). Therefore the normal ~/-globulin cannot account 
for  more  than  a  minor  fraction  of  the  Gin(a)  activity;  it  must  instead  be LARS  ~LRTENSSON  1173 
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FIG.  1.  Gm(a) determinations on myeloma sera.  Distribution of inhibitory titres in the 
Gin(a) test system for 18 Gin(a+) myeloma sera and for 10 Gin(a+) normal reference sera. 
In the upper diagram the myeloma sera have been diluted in the ordinary way; i.e., the 
dilutions indicated are the true dilutions of the sere. 
In the lower diagram the inhibitory titres have been corr~t~ with regard to the myeloma 
globulin concentrations; e.g., the inhibitory titre of a myeloma serum that contains myeloma 
"y-globulin in a  concentration 4  times as high as the concentration of *f-globulin in normal 
sera, has been reduced by a  factor of 4. Thus, the dilution designation 1/1 would refer to a 
myeloma globulin concentration of  10 mg/ml as  that is the approximate concentration of 
'y-globulin in normal sera. 
Myeloma sera which were entirely Gin(a--) have not been included. 
The inhibitory titres given in the diagrams represent the average of 3 determinations. The 
difference in titre between 2 determinations on 1 serum was at most 1 titre step. 
Inhibitory  titres 
of  the sera  corrected 
with  respect  to  the 
myeloma globulin 
concentration 
ascribed  mainly to Con(a+)  mydoma globulins. The Gin(a)  titres can be ex- 
plained,  partly  by  the  high  concentrations  of  the  myeloma  globulins .and 
partly by a higher activity per unit of protein for the myeloma globulins than 
for the whole 7-globnlins of normal Gin(a+)  sera  (Fig.  1, lower diagram). 
All sera and preparations examined contained at least 6 to 8 times as much myeloma globu- 
lin as normal "y-globulin (see Material and Methods and Table V). As exemplified, this made 
it possible to decide by quantitative considerations whether a  certain Gm activity demon- 
strated in the serum or the preparation should be ascribed to the myeloma protein or to the 
residual normal g-globulin; in other words, sera of categories B  and C  were readily distin- 1174  ~-GLOBULIN  GENES 
guished from one another. The distinction was facilitated still more by the high specific 
activity of myeloma globulins Gin(+) in respect of a particular Gm factor. 
First, 18 myeloma globulins (purified myeloma globulin fractions) of known 
Gm(a)  and  (b)  types  were  grouped  in  the  Gm(f)  system  (Table II).  They 
had been selected to include as many of the rare Gin(b+) myeloma globulins 
TABLE II 
~(/)  Types of lg Mydoma  Globulins Pr~o~ly  Typed/or  ~(a)  and Gin(b), and Sd=t~  to 
Include as Many C-re(b+) as Possible 
Type  (f+)  (f--) 
Gm(a--b+)  0  9 
Gm(a+b--)  0  4 
Gm(a-b-)  4  1 
TABLE III 
Gin(a),  (b), and Or) Type Frequencies among 24"12 (7S"1)-Myeloma Globulins and among Swedish 
Sera (i.e., Whole "y-Globulins from Normal Individuals) 
Type  Myeloma globulins,  No.  Sera 
Gm (a--{-b-k  f-b)  44 
Gm(a+b+f-) 
Gm(a+b--f+) 
Gm(a-b+f+) 
Gm(a+b-f-) 
Gm(a-b+f-) 
Gm(a-b-f+) 
Gm(a--b-f-) 
11 
h* 
10 
<1 
<1 
42 
13 
* Although type Gm(a-bTf-) is missing in these 24 myeloma globulins (not selected 
on the basis of Gm type), it does occur (see also Table II). 
as possible in the hope that the latter would provide critical information on 
the relationship between Gm(f) and Gm(b). All 9 Gm(b+) myeloma globulins 
proved Gm(f--). 
Second,  24  myeloma sera  were studied.  The only criteria of selection for 
these were that they should contain myeloma globulin of immunological "r2- 
type in  concentrations above 35  mg/ml  and  decreased  amounts  of  normal 
")'-globulin. The distribution of the Gin(a), (b), and (f) types among the mye- 
loma globulins is given in Table III. LARS M3~RTV.NSSON  1175 
The following points deserve special attention:  (a)  No myeloma globulins 
were positive for more than 1 of the factors Gm(a),  (b), and  (f), while about 
as many as 90 per cent of whole sera were positive for 2 or all 3 factors. In 
other words, none of the myeloma globulins appeared to contain the product 
or more than I of the 3 genes Gm  ~, Gm  b, and Gm  f, whereas the total "r-globulin 
of most individuals contains the product of 2  or of all 3  of these genes.  (b) 
The  types  Gm(a+b--f--)  and  Gm(a--b--f+)  represented  the  two  main 
groups  of  the  3'2-myeloma globulins;  each  comprised  roughly  40  per  cent. 
The types Gm(a-b-bf-)  and Gm(a--b-f--)  were minor groups. 
Immunologically  the  3  Gm(a-b-f-)myeloma  globulins  were,  like  the 
other  21,  of "Is  (7S'r)-type.  This  was  established  by immunoelectrophoresis 
(see Material and Methods). 
TABLE IV 
Can(x) Types of 24 "y~-Mydoma Globulins (the Same as in Table III) 
Type 
Gm(a+b-f--) 
Gm(a--b-[-f--)* 
Gm(a--b-f-b) 
Gin(a--b--f--) 
(x+) 
5 
(x-) 
6 
10 
3 
* The 9 myeloma globulins of type Gm(a--b+x--), which are not included in this table, 
were all Gm(x--). 
The  (relatively)  homogeneous  myeloma  globulins  were  generally  more 
strongly  inhibitory  than  the  heterogeneous  whole  3,-globulin  from  normal 
individuals positive with  respect to the  same factor:  (a)  The inhibitory ac- 
tivity of  Gm(b+)  myeloma globulins was 4  to 32  times as high  as  that  of 
whole ~,-globulins  from normal  Gin(b+)  individuals.  (b)  The Gm(f+) mye- 
loma globulins, on the other hand, were on the average only about twice as 
inhibitory per  unit  protein as  whole ~,-globulins  from normal  Gm(f+)  per- 
sons.  For Gm(a)  the corresponding ratio was also roughly 2:1  (Fig.  1). 
The myeloma globulins of all 42 sera and preparations were grouped with 
respect  to  Gm(x).  Six  of  them  were  Gm(x+),  the  remaining  36  Gm(x--). 
All 6  Gm(x+)  myeloma globulins  were  also  Gm(a-b).  Of  the  24  myeloma 
globulins that had not been selected according to Gm type, 11 were Gm(a+). 
Five of these 11 were Gm(x+)  (Table IV). The Gin(x-k) myeloma globulins 
were equally or at most 2 to 4 times as inhibitory per unit of protein as whole 
"r-globulin from Gm(x-k) normal individuals. 
Table V gives detailed data for each of the 24 myeloma sera. Due to scarcity of material 
Gin(f) and Gin(x) determinations were not performed on all sera in the dilution range per- 
mitring grouping of the normal "r-globulin. 1176  "y-GLOBULIN  GENES 
The  myeloma sera  and  myeloma globulin preparations  were initially investigated  with 
anti-Gm(f)  Mau.  Each  myeloma serum or preparation  could be  assigned  to one  of the 3 
above-mentioned categories, A, B, or C. 
Always when a  serum had been typed as Gin(f-)  with Matt.  the same result  was  ob- 
tained with A. J.  (category A), and when the Gm(f) activity could be accounted for by the 
normal "y-globulin, the 2 anti-Gin(f) sera gave parallel results (category B). Those myeloma 
TABLE V 
Crm  Groups of the Mydoma  Globulins and  of the Normal "y-Globulins in  the  Same  Sera 
Designations of the 
myeloma sera 
621 
707 
712 
722 
723 
743 
745 
786 
789 
814 
818 
823 
824 
827 
831 
844 
846 
879 
887 
888 
902 
9O3 
9O4 
9O8 
Gin(a) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Myeloma globulin 
Gin(x) 
+ 
+ 
+ 
+ 
+ 
Normal 7-globulin 
Gin(b)  Gin(f)  Gin(a) 
-  +  + 
--  --  -q- 
--  __  -J- 
--  --  -J- 
--  --  -q- 
-  +  + 
--  __  -q- 
--  .J-  -- 
--  --  -J- 
--  --[-  -- 
-  +  + 
-  +  + 
-  +  + 
--  --  -q- 
--  -q-  -- 
-  +  + 
~m( 
+ 
+ 
+ 
+ 
+ 
',+~ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Conc. of the 
myeloma globulin 
in  the  serum 
mg/ml 
41 
35 
63 
86 
71 
37 
48 
65 
50 
96 
65 
43 
52 
37 
47 
47 
62 
46 
88 
48 
39 
37 
68 
44 
globnling that had been typed as Gm(f+) with Mau., because they inhibited 1 to 4 times as 
strongly as whole ~/-globulin from normal Gm(f+) individuals (category C), gave unexpected 
results with A. J. Four of 10 myeloma globulins defined as Gin(f+) by Mau., also inhibited 
A. J. more strongly than normal whole Gin(f+) -y-globulin,  but the other 6 were less inhibi- 
tory. However, the inhibitory titres of these 6 sera were higher than what could be accounted 
for by the normal ~/-globulin. These myeloma globulins appeared to be Gin(f+) also as defined 
by A. J. though their activity was lower than that of some normal Gin(f+) ~'-globulin mole- 
cules. The molecular basis and the significance  of this observation is the subject of continued 
studies. TABLES VIa AND  VI b 
Con(a), (b), and (f) Types qf Anti-Rh Antibodies 
TABLE VIa 
Anti-Rh Sera Sdected Only  for High Titre in Coombs' Test, but Not on ~he Basis of Crm Type 
Gm type of the sera. 
Serum designation... 
Anfi-Gm(a) 
B.A. 
Stang. 
Anfi-Gm(b) 
I.G. 
Berg. 
Gary. 
Anti-Gin(f) 
Mau. 
(s+b-f-) 
1  2 
++  ++ 
++ 
++ 
++ 
++ 
(a+b-{.-f+) 
4  5 
++  ~++ 
++  ++ 
(-)  (-) 
1 
++  ++ 
6  7 
-  ++ 
-  + 
-  (+) 
++  (+) 
(a-b+f+) 
++ 
+ 
(+) 
++ 
8  9 
++ 
10 
++ 
TABLE VI b 
Sera Sdected because They Contain A nti-Rh Antibodies with Different Characteristics 
with Respect to Gin(a) and (b) 
}m type of the sera 
erum designation,. 
knti-Gm(a) 
B.A. 
Stang. 
knti-Gm(b) 
I.G. 
Berg. 
Gary. 
knti-Gm(f) 
Mau. 
a+b-{- 
f+ 
199 
-+ 
a-k4- 
f+ 
M.B. 
++ 
++ 
++ 
a+b+ 
f+ 
108 
m 
+q 
+q 
+q 
Columns 
a-b+  a+b+ 
f+  f+ 
Car.  SB 
-  ++ 
-  ++ 
++  + 
++ 
++ 
++  ++ 
II 
a+b+ 
f+ 
602 
++ 
++ 
B 
++ 
III 
a-b+  a-b+ 
f+  f+ 
695  418 
++  ++ 
Column I, anti-Rh sera found useful for Gm(b) typing systems; Column II, useful Gin(a) 
coats; Column III, sera with high titres in Coombs' test that do no render red cells aggluti- 
nable by anti-Gin(b), nor by anti-Gin(a); see Table VII. 
As tothe performance of the expefimentgiveninTablesVIa and VIb see Material and 
Methods. The ~gn,  ++,  denotes agglutination of maximal strength,  the sign,  --, denotes 
no agglutination. 
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Anti-Rh  Antibodies.--Eighteen  strong incomplete anti-Rh sera (titres above 
128 in Coombs' test) were used to coat Rh-positive red cells. The coated cells 
were  tested  for  agglutinability with  anti-Gm(a),  (b),  and  (f)  sera  (Tables 
VIa  and VI b). 
When an anti-Rh serum has been used to coat R.h-positive red cells and the cells have been 
washed,  the anti-Rh antibodies can be regarded  as "isolated." Agglutination of these cells 
by, say, an anti-Gin(a) serum indicates that some of the antibodies are Gm(a+), while non- 
agglutination indicates that none, or only relatively few, of the antibodies are Gm(a+). 
Judging  from  the  agglutination  reactions,  the  anti-Rh  antibodies  of 
Gm(b-}-f+)  sera  were  most  often  Gm(f-[-),  whereas  they  were  very  often 
Gm(b-).  The  anti-Rh  antibodies  of  Gin(a+)  sera  were  usually  Gm(a+). 
It may  also be  noted  that  the  anti-Rh  antibodies of  Gin(a-t-f-t-) sera  most 
often contained both Gm(a) and  Gm(f). 
Though,  e.g. sera  199  and  696  (see Tables VI b,  and  VII) provide clear instances  of 
predominantly  Gm(b-bf-)  respectively  Gm(b-f+)  anti-Rh  antibodies  occurring  in 
Gm(b+f+) sera, it should  be remarked that the former  type is rare. Serum  199 has been 
selected from a large number (50 to 100) of strong anti-Rh sera and M. B. has been sent to 
us as being particularly useful in Gin(b)  typing systems.  Most Gm(b-bf+) anti-Rh  sera- 
coated red cells effectively for anti-Gm(f) but poorly or not at all for anti-Gm(b) (Table 
VI a). 
Red cells coated with the 2 sera, M. B. and 199, which contain mainly Gm(b+f--) auti-Rh 
antibodies,  were definitely more strongly agglutinated by anti-Gin(b) than cells coated with 
any other anti-Rh antibodies;  including  e.g., the  Gm(b+f-b)  anti-Rh antibodies of sera 
I. K. and Car. This difference was striking when the agglutination tests were performed with 
a less sensitive technique; e.g., on slides or with aged cells. An increase in the amount of serum 
used to coat a certain quantity of red cells did not change  the result in these experiments, 
which indicates that the anti-Rh antibodies were present in excess during the coating (see 
Discussion). 
In  previous studies  (14)  the  anti-Rh  antibodies of many  anti-Rh  sera ap- 
peared to lack the products of known Gm genes. Five (Nos. 6, 9,  10, 418, and 
696)  of  the  sera  studied  in  the  present  investigation  contained  mainly 
Gin(a-b-)  anti-Rh antibodies. In all 5 instances the antibodies were clearly 
Gm(f-[-). 
Table VII gives the result of an experiment with 3  anti-Rh sera, 696,  199, 
and  S.  W.,  performed  before anti-Gm(f)  reagents  were  available. The  result 
clearly shows  that  in  these  instances  inability of an  anti-Rl~ serum  positive 
for  a  certain  Gm  factor  to  sensitize  the  ceils to  the  corresponding  anti-Gm 
was  not caused by too low a  concentration of antibodies during the coating. 
As only a  limited number  of anti-Rh  antibodies can  attach  themselves to  a 
cell these data do not make possible any exact estimate of the proportion of LARSM/~TENSSON  1179 
TABLE VII 
Experiment  Showing  That the  Products  of a  Gm  Gate Possessed  by  an  lndiddual  May  Be 
(at Least Largely)  Lacking among His Anti-Rh A "~tibodies 
Anti-.r-globulln  reagent used  Dilution of anti-Rh sermn 
totestthecoatedcells  "  5  ]  10  i  20  ]  40  80  [  160  i  320  i  640  1280 
Anti-Rh 199. Type of the serum: Gm(a+b+ ) 
Anti-Gin(a)  ......... 
Anti-Gm(b) 
Rabbitanfi_humanglob_  -db  ~  ~  ~  +  +  +  - 
ulin 
Anti-Rh S. W. Type of the serum: Gm(a+b+ ) 
Anti-Gin(a)  +  +  +  +  ..... 
Anti-Gin(b)  ..... 
Rabbit anti-human glob-  -4-  +  -4-  +  -4-  +  + 
ulin 
Anti-Rk 696. Type of the serum: Gin(a--b+) 
Anti-Gm(a)  ......... 
Anti-Gin(b) 
Rabbit anti-human glob-  +  +  +  +  +  +  + 
ulin 
Three anfi-Rh sera were used  to coat Rh-posifive cells. For the  coating  each  anti-Rh 
serum was used in 9 dilutions (1/5 to 1/1280). The coated cells were tested with anti-Gin(a), 
anti-Gm(b), and a rabbit anti-human globulin serum. The anti-Gin sera were used in 2 dif- 
ferent dilutions ruth a fourfold concentration difference. Both dilutions gave identical results 
indicating the presence of anfi-Gm in excess. A 2rid anti-Gin(a) and a 2nd anti-Gin(b) gave 
closely similar results. 
Serum 199 coated only for anti-Gin(b), although the whole serum was Gm(a+b+); serum 
SW, only for anti-Gm(a); and serum 696 neither for  anti-Gin(a) nor  for anti-Gm(b). The 
latter coats effectively for anti-Gin(f). (See Table VI b.) 
them  that  carries  a  particular  Gm-specificity.  But,  still,  it  seems  obvious 
that  at most  a  minor percentage  of the  anti-Rh  antibody molecules  can  be 
Gm(a+)  in  serum  199  or  Gm(b+)  in  serum  696. 
The  Inv(a)  and  (1)  type  of  the  anti-Rh  antibodies in  3  Inv(a+l+)  sera 
were  studied in  some  detail.  Dr.  Erna  van  Loghem,  Amsterdam,  who  pro- 
vided  2  of these  sera  (Nos.  2126  and  2264),  had  found  1  useful  for Inv  (1) 
typing systems and the other for Inv(a) typing systems. Dr.  A. G.  Steinberg 
who furnished  the 3rd  anti-Rh (Roehm) used it for Inv(a) and for Inv(1) sys- 
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The following experiment was done. The technique and the principle was the same as in 
the experiment referred to in Table VII: Red ceils of group O Rh-positive were coated with 
each of the 3 sera in different dilutions. The coated cells were subsequently tested with anti- 
Inv(a) and anti-Inv(1) sera. The highest dilution of each anti-Rh serum that rendered the 
cells agglutinable by anti-Inv (1) respectively anti-Inv(a) was determined. A fourfold increase 
in the concentration of the anti-Inv(a) or anti-Inv(1) used to test the coated cells did not affect 
the result, which indicates that an excess of agglutinator was present. Three anti-Inv(1) sera 
gave identical results. 
It proved that the ratio between the amount of anti-R_h serum needed to 
render the cells agglutinable by anti-Inv(a) and the amount needed to render 
them agglutinable by anti-Inv(1) was widely different for these 3 Inv(a+l+) 
sera.  For the  1st serum the ratio was greater than 16:1, it coated  for  anti- 
Inv(1)  in the dilutions up  to  1/16 but not  for  anti-Inv(a)  even  undiluted; 
for the 2nd anti-Rh serum the ratio was  1:8 and for the 3rd, 3:1.  In other 
words, the 2nd serum differed from the 1st by a factor of at least 128 and from 
the 3rd by a factor of about 24. These differences may be explained by the as- 
sumption  that  Inv(a)  and  Inv(1)  do  not cooccur in  the  same  molecules in 
Inv(a+l+) sera. 
DISCUSSION 
In recent years studies of "r-globulins  produced by 1 or by a  few clones of 
plasma cells,  myeloma globulins, and  certain  antibodies  (4--9, 14--16), have 
yielded valuable information on the Gm genes and on ~,-globulin synthesis in 
individual cells.  Such  investigations also  proved  essential for clarifying the 
relationship between Gm  f and the other 3"-globulin genes. 
Previous Studies of Gm Specificities in Isolated Myeloma Globulins and Specific 
Antibodies and the Gap in Our Knowledge Filled by the Information  on Gm(f).-- 
In extensive family and population studies on Caucasians Gm• and Gmb be- 
haved like alternate alleles (1-3).  The frequency of Gm  a is about 0.35 and of 
Gmb about 0.65 in Northern European populations (1). 
Though about 45 per cent of normal individuals possess both the gene Gm  ~ 
and the gene Gm  b, myeloma globulins have never been found to be Gm(a+b+). 
Most ~'2 (7S~/)-myeloma  globulins are  Gm(a+b--)  or Gm(a-b-),  and only 
some  10 per cent  Gin(a--b+)  (4,  6-8).  There  is evidence that also among 
normal ~/-globulin molecules types Gm(a+b-)  and Gin(a-b--)  are common 
and  type Gm(a--b+)  rare.  For example,  antibodies with a  single antibody 
specificity in Gm(a+b+) sera are often largely Gm(a+b--)  or, though more 
rarely, Gin(a--b+)  (5, 9); and it is common that anti-Rh and other ~,2-anti- 
bodies from Gm  b homozygotes are largely Gm(a--b--)  (9, 14). It has hitherto 
been  obscure  what  gene(s), if any, take the place of Gm  b (or  Gm  a)  in the 
synthesis of the Gin(a--b--) "y2-globulins. 
In this study the majority of Gm(a--b--)  myeloma globulins proved to be 
Gm(f+). Also, anti-Rh antibodies that had been classified as Gin(a--b--) were LARS M~RTENSSON  1181 
generally found to be dearly Gin(f+). These findings indicate that Gm  f takes 
part in the synthesis of most Gin(a-b-) 72-globulins in Caucasians. 
The Gm(a),  (b), and ~) Types of "r-Globulin Molecules and of the 7-Globulin 
Produced by One or a Few Cell Clones.--A myeloma globulin was never found 
to contain the product of more than one of the genes Gm  ~, Gm  b, and Gill  f 
(Tables II and In). This finding indicates,--for there are convincing reasons 
to believe that, at least with respect to Gm factors, most myeloma globulins 
represent essentially normal ~.-globulins in  abnormal concentration (see be- 
low),--that Gin(a), (b), and (f) do not (at least not as a rule) co-occur in the 
same molecule. They further show that these three types of 7~-globulins can 
be made, independently, in different cells (even in individuals possessing two 
or all three of the genes). 
The frequencies of the Gm types among myeloma globulln~ (Table III) may 
reflect the frequencies of these types among 72-globulin molecules in normal 
individuals.  If so, large proportions of the 7rglobulins of normais would be 
Gin(a+)  or Gin(f+), whereas only a  relatively small  proportion would be 
Gin(b+) (see Table HI). Genes not yet identified might be involved, in place 
of the Gm genes studied, in the synthesis of some 10 per cent (3 of 24 with due 
allowance for statistical variation) of the %-globulin molecules. 
Myeloma globulins positive for a  given Gm factor generally had a  higher 
activity per unit of protein than whole -y-globulin from Gin(+) persons. This 
difference is, in all probability, due to the greater homogeneity of the myeloma 
globulins. Only a proportion of the 7~-globulln of a normal individual carries 
the factor and this proportion is presumably equal to the quotient between 
the activity of his "y-globulin and the activity of the Gin(+)  homogeneous 
myeloma globulins. Also according to this line of thought only a minor frac- 
tion of the 7-globulin of normal individuals contains the products of the Gmb 
gene (see also 4, 6-8), whereas major fractions carry Gin(a) or Gin(f) (see Re- 
sults p. 1175). 
In the majority of Gin(a+) sera the anti-Rh antibodies were dearly Gin(a+). 
Similarly, the anti-Rh antibodies of Gin(f+) sera were most often also Gin(f+). 
In contrast, only a minor proportion of Gin(b+) anti-Rh sera sensitized  the 
cells to anti-Gin(b). Also this indicates that  among the "y-globulin molecules 
the Gin(a+) and the Gin(f+) predominate over the Gin(b+). 
Myeloma Globulins as Representatives of Normal  7-Globulins.--Different  in- 
dependent lines of reasoning support the major conclusions drawn concerning 
Gm genes and 7-globulin synthesis in normals: (a) The frequencies of the Gm 
types among normal 7-globnlln  molecules were estimated, first on the basis of 
the type frequencies among myeloma globulins and, second by comparing the 
specific activity of Gin(+) myeloma globulins and of whole "/-globulins from 
Gin(+) normal individuals.  The estimates arrived at were concordant. (b) The 
frequency distribution of the Gm types among anti-Rh antibodies agrees strik- 
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On the Mechanism of the Inactivity  of Gm Genes in Individual Plo3ma Cells.- 
Chromosome abnormalities in plasma cell  neoplasias of humans and of mice 
have been found by several workers,  but instances of plasma cell  myeloma 
with apparently normal karyotypes have also been reported (see references 17, 
18). It might be appropriate to consider whether elimination of some of a given 
individual's Gin genes from single plasma cells can feasibly be the correct ex- 
planation of the non-occurrence of Gm determinants in the products of these 
cells. 
Genes Gmb and Gin  f are located very close to one another on the chromo- 
some, so close that they are rarely, if ever, separated in meiosis in the Cau- 
casian population studied (see Table I  and below p. 1184). It is therefore un- 
likely that 1, but not the other, of these 2 genes should invariably be missing 
in myeloma cells owing to chromosomal loss in the (ontogenetic) history of the 
cell. These considerations favour the view that different Gin genes are present 
in the cell and can be switched on separately. 
Using immunofluorescence microscopy Colberg and Dray  (19)  determined 
the genetic type of T-globulin in rabbit plasma cells and concluded that in- 
dividual cells contain the products of both of 2 allelic genes. If this conclusion is 
taken for granted it appears as if normal plasma ceils may differ from myeloma 
cells in this respect. It is possible that Gm genes are inactivated to a varying 
degree in normal plasma cells; the myeloma cells may represent an extreme. 
The data  on anti-Rh  (see  also references  5,  14, 20, 21)  and other antibodies 
(9,  15,  16) suggest that in antibody producing cells  clones  in  humans  (5,  9, 
14,  20, 21) and in rabbits (15, 16) certain  Gm  genes may be  largely inactive 
or, possibly, involved in the synthesis of v-globulin lacking the particular anti- 
body specificity. 
Plasma Cell Myeloma,  a Single Cell Clone Committed  to the Synthesis  of 1 
Type  of  T-Globulin  Molecules.--That  no  myeloma  globulins  contained  the 
product of more than 1 of the genes, Gm  a, Gm  b, and Gin  *, gives strong support 
to the view that, as a  rule, the myeloma cells derive from a  single stem cell. 
The  v-globulin--synthesizing "machinery" of  this  stem  cell  is,  or  becomes, 
"locked" in such a way that its daughter cells can utilize only 1 of its Gm genes 
in the production of v-globulin. 
The concept of cell clones committed to the synthesis of one kind of T-globu- 
lin,--one kind of antibody,--is well established (see reference 22). The plasma 
cell population of an individual appears to be heterogeneous also in respect of 
Gm type. 
One may tentatively postulate that when a cell becomes committed to use 1 
Gm (and 1 Inv) gene for its T-globulin synthesis, this reflects a  commitment 
to the production of 1 kind of antibody. 
Anti-Rh Antibodies  and Their Properties as Components in the Gm Test Sys- 
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coating it must be derived from an individual positive for the Gm factor in 
question (20, 21). On the other hand, hlgh-titred incomplete anti-Rh sera from 
Gm(a-}-) or (b-{-) individuals were often found not to sensitize Rh-positive red 
cells to anti-Gin(a) respectively anti-Gm(b)  (20, 21). After studies of myeloma 
globulins had shown that Gm(a) and Gin(b) are probably contained in separate 
molecules (4), it was realized that the inability of an anti-Rh serum to coat for, 
say, anti-Gm(a) is due simply to absence of Gin(a-{-) anti-Rh antibodies, even 
though  the whole serum be Gin(a+)  (S).  Yet analysis of anti-Rh  sera and 
antibodies with respect to Gin(a) and (b) could not always explain  their prop- 
erties as Gm coats; e.g., why anti-R.h sera from Gmb homozygotes often fail to 
coat for anti-Gin(b) (14). 
The only 2 antibodies  from individuals  possessing  the gene Gm f  that were 
Gm(f-) proved to be Gm(bT)  (199 and M. B., see Table V). As a matter of 
fact, these  two highly selected  anti-Rh sera  are more useful as Gm(b) coats 
than any of the others.  We  can now reasonably explain why often  Gin(b-{-) 
anti-Rh sera  do not coat for anti-Gm(b) or do it very poorly,  no matter how 
much serum is  used to coat a certain  amount of red cells.  Most of  the antibody 
molecules are Gm(b-f-{-), and they block most Rh sites  and thereby prevent 
attachment of further  Gm(b-{-) antibody molecules.  The observations  on anti- 
Rh sera  199  and  M. B.  suggest  that,  to  be  a  first  quality  Gin(b) coat,  the  anti-Rh 
antibodies  of a serum should bc Gin(a-f--). Similarly,  serum 696,  which was 
selected  because the anti-Rh antibodies  in this  high-titred  serum appeared to 
be clearly  Gm(a--b-), now proved superior  as a Gin(f)  coat. 
It is well  known that incomplete antibodies can block the attachment of 
anti-Rh agglutinins  to red cells.  Obviously, an excess of one species  can also 
block the attachment of another species  of incomplete anti-Rh antibodies. 
Anti-Rh antibodies  of different  Gm  types in a serum compete for the sites 
on the red cells.  Therefore the anti-Rh antibodies  should include products of 
only I Gin gene, Gm ~, Gm b, or Gin  f,  if the red cells  are to be coated most ef- 
fectively  for the corresponding anti-Gin. 
On  the  Relationship  between Gin(a)  and Gm(x).--Gm(x-{-)  individuals  are 
practically always Gin(a+);  about half of all Gm(a+) North Europeans are 
Gin(x+) (23). The population data are compatible with the concept that Gin(a) 
and Gin(x)  are made be closely linked genes or that they are both formed by a 
single gene, called Gm  ~  (23). 
All the Gin(x+) myeloma globulins were found to be Gin(a+)  (Table IV). 
This finding indicates, that Gin(x)  occurs in the same molecules as Gin(a) and 
therefore supports the hypothesis that Gin(a) and Gm(x) are both formed by 
one and the same gene, the gene Gm  "*. The existence of Gin(a-k-x+) myeloma 
globulins  has also been reported previously (4, 6, 8). 
The frequencies of the 2 genes Gm  ~ and Gm  ~', as calculated from population 
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appear to be reflected in the frequencies of their products, as represented by 
the myeloma globulins. Of 11 Gm(a-4-) myeloma globulins, 5 were Gm(a-4-x-b) 
and 6 Gm(a-kx-) (Table IV). Nilsson (8) classified 6 out of 17 Gm(aq-) mye- 
loma globulins as Gm(xA-). 
Allelism and Linkage of Gm Ge~es.--Though the present investigation did 
not include studies of pedigrees it does justify some conclusions as to the mode 
of inheritance of Gm  f. In large family and population studies of Caucasians, 
performed by several authors, Gm  b appeared to be an alternate allele of Gm  a 
(1-3). These studies together with the observation (see Table I) that the char- 
acters Gin(b) and Gm(t~) practically always occur together in Whites appear to 
justify the conclusions, first,  that genes Gmb and Gm  f are located very close 
to one another on the chromosome and, second, that the chromosome segment 
with Gmb and Gm  t and the segment with the gene Gm  ~ are homologous. This 
implies  further that Gm  a is closely linked with another, as yet unidentified, Gin 
gene. 
It should be recollected that Gm  f, like Gm  a, is involved in the synthesis of a 
major fraction of the ~/2-globulin. This (as well as other data considered below) 
suggests that Gm  f, rather than Gm  b, is the true allele of Gm  ~. Gm  b, the products 
of which are found in only a  minor fraction of the "r2-globulin, should conse- 
quently be  the  allele of the postulated unidentified gene(s)  associated  with 
Gm  ~. This is in accord with the above conclusion (p. 1181) that unidentified Gm 
genes participate in the synthesis of only a minor proportion of the ~,2-globulin 
molecules in individuals of common Gm types. 
It is well established that genes Gm  ~ and Gm  b cannot be alleles in Negroes, as 
practically all Negroes are  Gm(a-bb-b)  (24). Of 10 American Negro sera available 
7 were found to be Gm(a÷bq-f-), a very rare type in Caucasians, and 3 were Gm 
(a4-b-bf-b).  It is obvious that type Gin(f-) is much more common in Negroes than 
in Whites (see Table I). It has been estimated that around ~  of the gene pool of the 
American Negro population is of Caucasian origin (25). The occurrence of type Gm 
(f-b)  in 3 out of 10 American Negroes can be accounted for by Gm  f genes of Cau- 
casian origin. However, Gold et al have found that type Gm(f  +) does, indeed, occur 
with a low frequency in African Negroes (10). 
The gene Gm  a has a very high frequency in Negroes (2) and a  much lower 
in Caucasians. Therefore a  true allele of Gm  ~ has to be relatively infrequent 
in Negroes.  Gm  t, but not Gm  b, fulfils this criterion. On  the other hand, an 
observation that 25, out of 27 Chinese were Gm(b-kfd-) (10),--together with 
previous reports on the frequency of type Gm(ad-)  (2),--appears  to indicate 
that the great majority of individuals in this population are Gm(a-kb-kf-k); 
this would obviously preclude (at least for certain populations) the hypothesis 
that the specificities  Gin(a) and Gin(f), or Gm(a) and Gin(b), are elaborated 
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Harboe et al.  (6) found all d  6 myeloma globulins from Negroes to be Gm 
(a+b--) and not Gm(a+b+)  as might have been suspected from the current 
hypothesis that all Negroes are homozygous for a gene Gm  "b (24). This finding 
was suggestive evidence, first, that Gm• and Gmb  are indeed distinct, though 
closely linked  genes  in  Negroes  and,  second,  that  Gm• in  Negroes,  like  in 
Whites, expresses its information in a much larger proportion of the ~,~-globulin 
molecules than Gmb. It appears that in Negroes a gene complex with Gm~Gm  b 
predominates, whereas a complex with C,m~Gm  b is most common in Caucasians. 
Grey and Kunkel have demonstrated the existence of 3  distinct classes of 
~-myeloma  globulins,  each  possessing  characteristic  antigenic  determinants 
ascribable to the H  (heavy polypeptide) chains (26). It has been shown that 
the Gm(a+) and the Gin(f+) myeloma globulins belong in 1, and the Gin(b+) 
in another, of these 3 antigenic classes (27). This is another strong argument 
against  the hypothesis that  Gmb is the allele of Gm  ~. 
Neel  (28)  and others discussed the hemoglobin genes as a  "remarkable ex- 
ample  of the  clustering of related genetic functions on a  single mammalian 
chromosome." Apparently,  the  same  statement can be  made about the  ~,a- 
globulin genes. There are 2 (or more) closely linked loci for Gin genes. It seems 
likely that there are 2 or more loci also for Inv genes. 
The Gm genes are apparently engaged in the synthesis of the A (H) chains of the 
"y2-globulin, the Inv genes in the synthesis of B (L) chains (29-31). Inv(a) and Inv(1) 
are characters which, like Gm(b) and Gin(f), generally occur together in Caucasians 
(32). More than 99 per cent of Europeans are either Inv(a+l+) or Inv(a-1-) (32). 
The current hypothesis has been that Inv(a) and Inv0) are formed by one and the 
same gene, Inv  ~l  (32). The findings on the anti-Rh antibodies  of three Inv(a+l+) 
sera  (see Results)  suggest  that Inv(a) and Inv(1)  occur in separate molecules and 
therefore that they are formed by different genes. On this line of thought the relation- 
ship between genes Inv  ~ and Inv~ is analogous to that between  Gmb and Gin f. 
It may be remarked that if there exist 2 to 4 loci for A chain genes as well as for 
B chain genes at least as many as (4 X 4 =) 16, (6 X 6 =) 36, or (8 X  8 =)  64 types 
of molecules could possibly be formed in one individual,  if the product of any of the 
A chain genes can be combined with the product of any of the B chain genes. 
The existence of more than  1 locus for genes involved in the synthesis of 
polypeptide chains either of which can occupy a given position in the y-globulin 
molecule considerably increases the number of genotypicaily determined dis- 
tinct subtypes of the immunoglobulins. This reduces the amount of variation 
in the structure of these proteins that may have to be accounted for by agents 
other  than  inheritable  genes. 
SD~r~Ry 
Gm types of sera from Caucasians and Negroes, of myeloma globulins, and 
of specific antibodies were investigated. In particular the relationship between 
the recently identified gene Gm  f and other Gm genes was analyzed. 1186  "r-GLObULIn G~s 
1.  Caucasians were, with rare exceptions, either Gm(b+f+) or Gin(b--f--). 
2.  In Negroes, on the other hand, type Gm(b+f-)  was found to be com- 
mon. 
3.  No myeloma globulins appeared to contain the product of more than 1 
of the 3 genes Gm  ~, Gm  b, and Gm  f, even though the large majority of normal 
individuals, as well as myeloma patients, possess 2 or all 3  of these genes. 
4.  The types Gm(a+b-f-)  and  Gm(a-b-f+)  represented the 2 major 
groups among the ~/2-myeloma globulins; each comprised roughly 40 per cent. 
The types Gm(a-b+f--)  and  Gin(a--b-f-)  are minor groups. 
5.  All  Gm(x+) myeloma globulins were also Gm(a+). Approximately half 
of  the  Gm(a+)  myeloma globulins  were  Gin(x+). 
6.  In the majority, but not in all, of Gm(a+)  sera the anti-Rh antibodies 
were clearly Gin(a+). Similarly, the anti-Rh antibodies of Gin(f+) sera were 
most often, but not always, also Gin(f+). In contrast, only a minor proportion 
of Gm(b+)  anti-Rh  sera sensitized  red  cells to  anti-Gin(b). 
The author is particularly indebted to Dr. R. Bachmann, Dr. C.-B. Laurell, and Dr. U. 
Nilsson, Department of Clinical Chemistry, Malta5 General Hospital, MalmS, who provided 
most of the myeloma  sera studied, and to Dr. J. Andersen, State Serum  Institute, Copenhagen, 
Denmark, for generous gifts of many anti-Rh sera. 
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